Psychiatry

Clinical evidence, research, and medical intelligence in Psychiatry.

Cannabidiol and Risky Decision-Making in Alcohol Use Disorder

A Journal of the National Cancer Institute abstract examines cannabidiol’s effects on risky decision-making and autonomic function in alcohol use disorder.

By Dr. A. Manasa, MBBS · Oct 21, 2026 · 5 min read

Psychiatry·Cancer Cell

Forward Genetic Screens in Animal Models Offer New Psychiatric Disease Clues

A review in Neuroscience and Biobehavioral Reviews examines forward genetic screens in worms, flies, zebrafish, and mice for…

Oct 21, 2026

Psychiatry·medRxiv

LabWAS links polygenic risk to biomarker patterns in psychiatric disorders

Penn Medicine Biobank analysis mapped psychiatric polygenic scores to lab and vital sign patterns, suggesting biologic signatures of…

Oct 21, 2026

Psychiatry·Gut

Gut Microbiome Differs in Clozapine-Treated Treatment-Resistant Schizophrenia

A pilot case-control study found reduced gut microbial diversity and distinct taxa in clozapine-treated treatment-resistant schizophrenia versus healthy…

Oct 21, 2026

Psychiatry·BMJ

GLP-1 drugs linked to fewer psychiatric crises in schizophrenia and diabetes

Observational US data link GLP-1 receptor agonists with fewer psychiatric hospital admissions and emergency visits in schizophrenia plus…

Oct 21, 2026

Psychiatry·JAMA

Online Sports Betting Legalization Linked to Higher Mental Health Care Use

A national claims study found online sports betting legalization was associated with more outpatient depression and anxiety care…

Oct 21, 2026

Psychiatry·DailyMed

Mirtazapine ODT label updates reinforce safety, dosing, and interaction precautions

DailyMed’s updated mirtazapine orally disintegrating tablet label details adult MDD use, boxed warning, dosing, and key safety risks.

Oct 21, 2026

Psychiatry·MHRA

Mental Health Support Worker Role Expands Residential Care in Bromborough

Bromborough residential service seeks a mental health support worker to help young people with daily living, self-harm management,…

Oct 21, 2026

Psychiatry·WMH

GH001 psychedelic trial shows rapid postpartum depression remission

A phase 2a trial found rapid symptom reduction with inhaled GH001 in postpartum depression, but safety, durability, and…

Oct 21, 2026

Psychiatry·Br J Cancer

ADHD Linked to Higher Risk of Psychotic Disorders, Review Warns

A Molecular Psychiatry perspective examines ADHD and later psychotic disorders, including bipolar disorder, schizophrenia risk, and screening implications.

Oct 21, 2026

Psychiatry

Clinical evidence, research, and medical intelligence in Psychiatry.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.